Lupin bags tentative FDA approval for Tolvaptan Tablets, a generic of Jynarque
Lupin Limited, a global pharmaceutical powerhouse, proudly announces that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Tolvaptan Tablets, encompassing strengths of 15 mg, 30 mg, 45 mg, 60 mg, and 90 mg. These tablets serve as a generic equivalent to […]